SCHEMBL2065876

SCHEMBL2065876

CCN(C1CC1)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2066596 0.90 ADH1A (0.42) —
SCHEMBL20160972 0.88 ADH1A (0.48) —
SCHEMBL516222 0.87 ADH1A (0.46) —
SCHEMBL5703370 0.84 ADH1A (0.50) —
SCHEMBL23038 0.84 ADH1A (0.50) —
SCHEMBL5703310 0.84 ADH1A (0.50) —
SCHEMBL19710776 0.84 PIK3CD (0.43) —
SCHEMBL736433 0.84 — —
Bromide SCHEMBL11846706 0.82 ADH1A (0.48) —
Hydrochloric Acid SCHEMBL2140609 0.82 ADH1A (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023083373-A1 COMPOUND USED AS SRC INHIBITOR 微境生物医药科技(上海)有限公司 2023-05-19 — — WO disclosed
EP-2076558-B1 COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME DOW CORNING (US) 2018-04-18 — — EP disclosed
US-9181253-B2 Adenosine receptor agonists, partial agonists, and antagonists THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2015-11-10 — — US disclosed
US-20120252823-A1 ADENOSINE RECEPTOR AGONISTS, PARTIAL AGONISTS, AND ANTAGONISTS SERVICES (US) 2012-10-04 — — US disclosed
US-8147789-B2 Composition comprising neopentasilane and method of preparing same DOW CORNING CORPORATION (US) 2012-04-03 — — US disclosed
US-20100176338-A1 Composition Comprising Neopentasilane And Method Of Preparing Same NATA SEMICONDUCTOR MATERIALS CO., LTD. (CN) 2010-07-15 — — US disclosed
EP-2076558-A1 COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME Dow Corning Corporation (US) 2009-07-08 — — EP disclosed
WO-2008051328-A1 COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME DOW CORNING CORPORATION (US) 2008-05-02 — — WO disclosed
CN-101119747-A Tissue factor production inhibitor SANKYO CO (JP) 2008-02-06 — — CN disclosed
CN-101094827-A Benzene compound having two or more substituents SANKYO CO (JP) 2007-12-26 — — CN disclosed
Send feedback